B.C based company could help revolutionize treatment of diabetes

  • 📰 TerraceStandard
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

Business News News

Business Business Latest News,Business Business Headlines

Province invests almost $24 million into life-sciences firm Aspect Biosystems

A B.C.-based company could end up revolutionizing diabetes treatment and that is a reason why B.C. put up almost $24 million to keep it in B.C. rather than lose it to Denmark.

"So it's a very attractive company, if they are successful, and we think they will . It has the opportunity to completely revolutionize how people living with diabetes manage their diabetes and many other diseases as well." Looming behind B.C.'s move is the larger question of whether it is appropriate to use public funds to support a private company rather than let market forces play out.

Noting that B.C.'s economy is similar to that of Ireland, Bailey added that that country has used its tax system to build one of the largest life-sciences and pharmaceutical sectors in the world.Other examples abound. They include the European Union's Green New Deal and the Inflation Reduction Act in the United States — policies backed by hundreds of billions to achieve certain economic outcomes.

She also said that both the provincial and federal government go through a great deal of due diligence to protect the investment of taxpayers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 24. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Vancouver company that 3-D prints live tissue for pancreas, liver implants receives $73-million from B.C., OttawaThe funding will help Aspect Biosystems build a manufacturing plant capable of producing materials for its clinical trials and investments to further develop its technology
Source: globebusiness - 🏆 31. / 66 Read more »